Literature DB >> 8608818

2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells.

K Ikemoto1, M Kobayashi, T Fukumoto, M Morimatsu, R B Pollard, F Suzuki.   

Abstract

2-Carboxyethylgermanium sesquioxide (Ge-132), a synthesized organogermanium compound with immunomodulating activities, was shown to be an inducer of anti-suppressor T cells in normal mice. The suppressor cell activity of T6S cells, a clone of burn-induced CD8+ IL-4-producing suppressor T cells, was clearly inhibited when a mixed lymphocyte-tumor cell reaction of the clone was conducted with splenic mononuclear cells from mice treated orally with a 100 mg/kg dose of Ge-132. The activity of anit-suppressor cells was demonstrated in spleens of mice 2 days after treatment with Ge-132 and reached its peak on day 3. The anti-suppressor cells induced by the compound were of a contrasuppressor T cell-linage, because they were characterized as CD4+ CD28+ TCRalpha/beta+ Vicia villosa lectin-adherent T cells. These cells produced IFN-gamma but did not produce IL-2, IL-4, IL-6 or IL-10 in their culture fluids. CD4+ anti-suppressor T cells induced by Ge-132 may be different from other subsets of CD4+ T cells because Th1 and Th2 cells generated in our laboratory did not adhere to Vicia villosa lectin-coated petri dishes, and each produced specific cytokines. Th1 cells produced IFN-gamma and IL-2 while Th2 cells produce IL-4 and IL-10 in vitro. These results suggest that Ge-132 may be useful as an inducer of contrasuppressor T cells in immunocompromised individuals bearing suppressor T cells. To eliminate suppressor T cells from immunocompromised hosts may result in improved resistance from various opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608818     DOI: 10.1007/bf01923363

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  43 in total

1.  Postburn immunosuppression in an animal model. IV. Improved resistance to septic challenge with immunomodulating drugs.

Authors:  R L Zapata-Sirvent; J F Hansbrough; E M Bender; E J Bartle; M A Mansour; W H Carter
Journal:  Surgery       Date:  1986-01       Impact factor: 3.982

2.  The role of T-cell subsets and cytokines in the regulation of infection.

Authors:  P Scott; S H Kaufmann
Journal:  Immunol Today       Date:  1991-10

Review 3.  The role of TH1 and TH2 subsets in human infectious diseases.

Authors:  G Del Prete; S Romagnani
Journal:  Trends Microbiol       Date:  1994-01       Impact factor: 17.079

4.  Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay.

Authors:  T R Mosmann; J H Schumacher; D F Fiorentino; J Leverah; K W Moore; M W Bond
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

Review 5.  Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.

Authors:  A Sher; R T Gazzinelli; I P Oswald; M Clerici; M Kullberg; E J Pearce; J A Berzofsky; T R Mosmann; S L James; H C Morse
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

Review 6.  Suppressor T cells and the immune response to tumors.

Authors:  S Schatten; R D Granstein; J A Drebin; M I Greene
Journal:  Crit Rev Immunol       Date:  1984       Impact factor: 2.214

Review 7.  Stigma variations: observations on suppressor T cells and leprosy.

Authors:  B R Bloom; R L Modlin; P Salgame
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 8.  Biological activities and antitumor mechanism of an immunopotentiating organogermanium compound, Ge-132 (review).

Authors:  R R Brutkiewicz; F Suzuki
Journal:  In Vivo       Date:  1987 Jul-Aug       Impact factor: 2.155

9.  Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists.

Authors:  D E Griswold; S Alessi; A M Badger; G Poste; N Hanna
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  Contrasuppression. A novel immunoregulatory activity.

Authors:  R K Gershon; D D Eardley; S Durum; D R Green; F W Shen; K Yamauchi; H Cantor; D B Murphy
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

View more
  2 in total

1.  Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries.

Authors:  T Katakura; T Yoshida; M Kobayashi; D N Herndon; F Suzuki
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.

Authors:  Jung Min Cho; Jisuk Chae; Sa Rang Jeong; Min Jung Moon; Dong Yeob Shin; Jong Ho Lee
Journal:  PLoS One       Date:  2020-10-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.